Legend Biotech Corporation (ADR) share price logo

Legend Biotech Corporation (ADR)

NASDAQ: LEGN

Mid Cap

$28.03

-1.88

(-6.29%)

as on

Legend Biotech Corporation (ADR) Stock Performance

as on July 7, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $27.56
    $29.80
    downward going graph

    1.68%

    Downside

    6.31%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $16.24
    $45.30
    downward going graph

    42.06%

    Downside

    61.60%

    Upside

    downward going graph

Legend Biotech Corporation (ADR) share price movements today

Previous Close
$29.91
Open
$29.80
Volume
1.5M
Day's Low - High
$27.56 - $29.80
52 Week Low - High
$16.24 - $45.30

Legend Biotech Corporation (ADR) Historical Returns

1 Month Return
-8.31 %
3 Month Return
+ 60.12 %
1 Year Return
-16.08 %
3 Year Return
-56.46 %
5 Year Return
-24.01 %

Legend Biotech Corporation (ADR) Stock Fundamentals & Key Indicators

Check Legend Biotech Corporation (ADR) market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$5.8B

EPS (TTM)

0.28

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-125.1M

Revenue (TTM)

1.1B

Profit Margin

-21.96%

Return On Equity TTM

-25.19%

Legend Biotech Corporation (ADR) vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Legend Biotech Corporation (ADR) with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$5.8B-24.01%NA-21.96%NA
BUY$40.2B501.91%NA0.00%NA
BUY$41.8B79.37%78.7912.55%NA
BUY$134.0B163.95%31.3635.51%NA
BUY$68.6B12.37%15.9729.65%0.5700000000000001%

Stock Returns calculator for Legend Biotech Corporation (ADR) Stock including INR - Dollar returns

The Legend Biotech Corporation (ADR) stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Legend Biotech Corporation (ADR) investment value today

Current value as on today

₹87,484

Returns

-₹12,516

(-12.52%)

Returns from Legend Biotech Corporation (ADR) Stock

-₹21,352 (-21.35%)

Dollar Impact

₹8,836 (+8.84%)

Analyst Recommendation on Legend Biotech Corporation (ADR) Stock

Based on 27 analysts

BUY

88.89%

Buy

11.11%

Hold

0.00%

Sell

Based on 27 analysts, 88.89% of analysts recommend a 'BUY' rating for Legend Biotech Corporation (ADR). Average target price of $57.24

Legend Biotech Corporation (ADR) Share Price Target

Get share price movements and forecasts by analysts on Legend Biotech Corporation (ADR).

What analysts predicted

51.03%UPSIDE

Target Price

$57.24

Current Price

$28.03

Analyzed by

27 Analysts

Target

$57.24

Legend Biotech Corporation (ADR) target price $57.24, a slight upside of 51.03% compared to current price of $28.03. According to 27 analysts rating.

Indian Investors' Interest in Legend Biotech Corporation (ADR) Stock

Search interest for Legend Biotech Corporation (ADR) Stock has increased by 58% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:58% versus previous 30 day period

Legend Biotech Corporation (ADR) Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
79
93
186
160
186
195
255
272
306
305
Gross Profit
47
39
136
104
112
123
157
157
182
129
Operating Income
-119
-117
-41
-70
-74
-50
-21
-43
-20
-49
EBITDA
-135
-48
-7
-109
52
-88
-113
-33
-2
-32
Interest Expense
5
5
5
5
5
5
5
5
5
5
Depreciation
5
5
5
5
6
5
5
5
11
15
Income Before Tax
-146
-59
-17
-120
40
-99
-124
-39
-19
-53
Income Tax Expense
-1
0
0
4
14
1
0
0
11
1
Net Income
-144
-59
-18
-125
26
-100
-125
-39
-30
-54
Net Profit Margin
-182.24%
-63.62%
-9.76%
-78.23%
14.09%
-51.74%
-49.16%
-14.57%
-10.06%
-17.80%

Legend Biotech Corporation (ADR) Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
23
49
61
75
68
117
285
627
1,028
Gross Profit
23
49
61
75
68
51
140
392
620
Operating Income
13
-1
-132
-313
-392
-455
-439
-303
-136
EBITDA
14
0
-129
-298
-392
-416
-477
-113
-232
Interest Expense
-
0
0
4
0
10
21
21
21
Depreciation
-
1
5
9
13
18
20
23
28
Income Before Tax
13
-1
-127
-308
-407
-445
-520
-158
-282
Income Tax Expense
4
1
-25
-41
-3
0
-1
18
14
Net Income
9
-2
-101
-266
-403
-446
-518
-177
-296
Net Profit Margin
39.69%
-5.67%
-164.39%
-355.16%
-586.38%
-381.48%
-181.75%
-28.22%
-28.85%

Legend Biotech Corporation (ADR) Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-59
-17
-120
40
-99
-124
-39
-30
-54
Operating Cash Flow
15
-1
-75
-82
-103
-13
28
-105
-85
Investing Cash Flow
-396
-695
329
-87
256
-165
-20
640
-168
Financing Cash Flow
0
0
4
0
0
0
0
0
-1
Change in Cash
-380
-696
258
-172
154
-175
12
622
-255

Legend Biotech Corporation (ADR) Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-1
-130
-308
-407
-445
-520
-158
-297
Operating Cash Flow
307
-83
-223
-198
-201
-393
-144
-100
Investing Cash Flow
-102
-58
-24
-194
-77
92
-850
711
Financing Cash Flow
2
14
618
626
377
791
5
0
Change in Cash
208
-126
372
233
97
491
-990
615

Global Institutional Holdings in Legend Biotech Corporation (ADR)

Funds
Holdings
ArrowMark Colorado Holdings, LLC (ArrowMark Partners)
0.39%
UBS Group AG
0.55%
BlackRock Inc
2.52%
Two Sigma Investments LLC
1.02%
Goldman Sachs Group Inc
0.51%

Legend Biotech Corporation (ADR) News & Key Events

  • img

    Today's Timeline - 22 June

    Mon, 07:44 PM

    -

    Legend Biotech reports promising results for LB2501, showing complete response in five of six patients at the highest dose.

    Tue, 02:58 AM

    -

    Legend Biotech prices $226 million ADS offering to support cell therapy expansion and strengthen its balance sheet.

Insights on Legend Biotech Corporation (ADR)

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, LEGN stock has moved up by 66.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Revolution Medicines, Inc. Common Stock has given 416.1% return, outperforming this stock by 432.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 617.1% return, outperforming this stock by 673.7%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 306.37M → 305.1M (in $), with an average decrease of 0.4% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, -30.81M → -54.3M (in $), with an average decrease of 76.2% per quarter

About Legend Biotech Corporation (ADR)

Legend Biotech Corporation, through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe. Its lead product candidate is ciltacabtagene autoleucel, or cilta-cel, which is a chimeric antigen receptor (CAR-T) therapy for the treatment of multiple myeloma (MM). The company also has a portfolio of earlier-stage autologous CAR-T product candidates targeting various cancers, including acute lymphoblastic leukemia, gastric cancer, esophageal cancer, pancreatic cancer, colorectal cancer, small cell lung cancer, and non-small cell lung cancer. In addition, it develops allogeneic gamma delta CAR-T and allogeneic CAR-NK product candidates targeting B-cell maturation antigen (BCMA) for MM, which are in investigator-initiated Phase 1 clinical trials in China. The company has a collaboration and license agreement with Janssen Biotech, Inc. for the development and commercialization of cilta-cel, as well as a license agreement with Novartis Pharma AG for the development, manufacture, and commercialization of CAR-T cell therapies targeting delta-like ligand protein 3. Legend Biotech Corporation was founded in 2014 and is headquartered in Somerset, New Jersey.
OrganisationLegend Biotech Corporation (ADR)
Headquarters2101 Cottontail Lane, Somerset, NJ, United States, 08873
IndustryBiotechnology
CEODr. Ying Huang Ph.D.
E-voting on sharesClick here to vote

Key Management of Legend Biotech Corporation (ADR)

Name

Title

Ms. Jessie Yeung M.B.A.

Vice President of Finance, Investor & Public Relations

Ms. Ananda Elizabeth Martin Esq., J.D.

Global Compliance Officer

Mr. Alan S. Bash

President of CARVYKTI®

Ms. Joanne Choi

Senior Manager of Investor Relations

Dr. Ying Huang Ph.D.

CEO & Director

Mr. James Pepin J.D.

General Counsel

Dr. Guowei Fang Ph.D.

President of Research & Development

Mr. Birk Vanderweeen

Senior Vice President of Global Manufacturing & Supply

Surabhi Verma

Manager of Investor Relations & Corporate Communications

Mr. Carlos Santos

Chief Financial Officer

FAQs

What is Legend Biotech Corporation (ADR) share price today?

Legend Biotech Corporation (ADR) share price today is $28.03 as on at the close of the market. Legend Biotech Corporation (ADR) share today touched a day high of $29.80 and a low of $27.56.

What is the 52 week high and 52 week low for Legend Biotech Corporation (ADR) share?

Legend Biotech Corporation (ADR) share touched a 52 week high of $45.30 on and a 52 week low of $16.24 on . Legend Biotech Corporation (ADR) stock price today i.e. is closed at $28.03,which is 38.12% down from its 52 week high and 72.60% up from its 52 week low.

What is Legend Biotech Corporation (ADR)'s market capitalisation today?

Legend Biotech Corporation (ADR) market capitalisation is $0.01T as on .

How to invest in Legend Biotech Corporation (ADR) Stock (LEGN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Legend Biotech Corporation (ADR) on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Legend Biotech Corporation (ADR) Shares that will get you 0.0535 shares as per Legend Biotech Corporation (ADR) share price of $28.03 per share as on July 7, 2026 at 1:29 am IST.

What is the minimum amount required to buy Legend Biotech Corporation (ADR) Stock (LEGN) from India?

Indian investors can start investing in Legend Biotech Corporation (ADR) (LEGN) shares with as little as ₹95.395 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹953.95 in Legend Biotech Corporation (ADR) stock (as per the Rupee-Dollar exchange rate as on ). Based on Legend Biotech Corporation (ADR) share’s latest price of $28.03 as on July 7, 2026 at 1:29 am IST, you will get 0.3568 shares of Legend Biotech Corporation (ADR). Learn more about fractional shares .

What are the returns that Legend Biotech Corporation (ADR) has given to Indian investors in the last 5 years?

Legend Biotech Corporation (ADR) stock has given -24.01% share price returns and 27.65% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?